Intercell: EU Invests € 30m in Research Program

Published: September 29, 2011; 14:26 · (Vindobona)

The Austrian pharmaceutical company will receive co-funding for a collaborative research project from the European Union.

Intercell: EU Invests € 30m in Research Program / Picture: © Intercell

Intercell AG today announced that on 1 October 2011 the collaborative research program – Advanced Immunization Technologies (ADITEC) – will start in order to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines. ADITEC is co-funded with € 30m by the European Commission to establish a robust platform for innovation…

This article includes a total of 268 words.

or Log In

Fast News Search

Join us to succeed in Vienna! Sign up to read articles for free and to get personalized updates on the events that interest you.

Intercell: EU Invests € 30m in Research Program

The Austrian pharmaceutical company will receive co-funding for a collaborative research project from the European Union.

Join us to succeed in Vienna!
Sign up to read articles for free and to get personalized updates on the events that interest you.